Dermatology · Jeffersonville, IN
NPI
1184120602
Since 2018
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
265 Quartermaster Ct
Jeffersonville, IN, 47130
Phone (812) 932-2387
Groups this clinician bills Medicare through
Medicare paid, 2024
$242K
5,556 services
Medicare patients, 2024
1,022
Average age 75
Drug cost, 2024
$1.5M
1,706 prescriptions
Company payments, 2025
$3,301
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elena M Kurland was code 17003 (destruction skin lesion), 2,127 times for 365 patients. In total Elena M Kurland billed 5,556 services in 76 codes, and Medicare paid $242K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,127 | 365 | $4.80 | $10K |
| 99213 Office E&M - Established | Office | 639 | 501 | $58.53 | $37K |
| 17000 Destruction Skin Lesion | Office | 556 | 425 | $33.42 | $19K |
| 99214 Office E&M - Established | Office | 451 | 326 | $88.34 | $40K |
| 11102 Skin Biopsy | Office | 378 | 331 | $62.69 | $24K |
| 17110 Destruction Skin Lesion | Office | 278 | 230 | $74.15 | $21K |
| 11103 Skin Biopsy | Office | 132 | 90 | $37.41 | $4,938 |
| 99203 Office E&M - New | Office | 103 | 103 | $65.04 | $6,699 |
| 99204 Office E&M - New | Office | 84 | 84 | $98.66 | $8,287 |
| 12032 Wound Repair - All Levels | Office | 57 | 55 | $217.62 | $12K |
| 17262 Destruction Skin Lesion | Office | 52 | 43 | $110.85 | $5,764 |
| 99212 Office E&M - Established | Office | 51 | 47 | $35.31 | $1,801 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 51 | 25 | $0.73 | $37.15 |
| 11603 Skin Lesion Excision | Office | 44 | 42 | $107.98 | $4,751 |
| 11900 Skin | Office | 41 | 22 | $28.86 | $1,183 |
By year: 2022 $33K for 626 services; 2023 $178K for 4,119 services; 2024 $242K for 5,556 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elena M Kurland prescribed most often to Medicare patients was Clobetasol Propionate, with 227 prescriptions and refills. In total Elena M Kurland wrote 1,706 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 227 | 232 | 115 | $8,220 |
| Ketoconazole Generic | 225 | 231 | 120 | $2,772 |
| Triamcinolone Acetonide Generic | 197 | 213 | 134 | $1,638 |
| Hydrocortisone Generic | 107 | 107 | 62 | $350 |
| Fluorouracil Generic | 79 | 79 | 71 | $6,615 |
| Minoxidil Generic | 64 | 132 | 17 | $497 |
| Tacrolimus Generic | 47 | 47 | 34 | $6,657 |
| Ciclopirox Generic | 36 | 36 | 11 | $831 |
| Spironolactone Generic | 34 | 63 | 12 | $519 |
| Doxycycline Hyclate Generic | 34 | 36 | 26 | $393 |
| Prednisone Generic | 34 | 34 | 22 | $133 |
| Betamethasone Valerate Generic | 32 | 32 | 24 | $1,151 |
| Clindamycin Phosphate Generic | 30 | 39 | 14 | $1,459 |
| Metronidazole Generic | 27 | 29 | 18 | $1,754 |
| Finasteride Generic | 27 | 57 | Under 11 | $209 |
Brand drugs: 193 claims; generic drugs: 1,513 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elena M Kurland $3,301 ($3,301 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $514.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $514 |
| Janssen Biotech, Inc. JNJ | 16 | $511 |
| UCB, Inc. UCB.BR | 19 | $448 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $331 |
| Galderma Laboratories, L.P. GALD.SW | 20 | $282 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $201 |
| Genzyme Corporation SNY | 10 | $187 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $164 |
| Incyte Corporation INCY | 3 | $79.2 |
| Hill Dermaceuticals, Inc. | 1 | $74.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.